Stock Market News2 months Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think “Yes” Zacks
BioMarin (BMRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
X2 days Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term Zacks
X7 days Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock? Zacks
X2 weeks BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy? Zacks
X4 weeks Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report? Zacks
X1 month Biomarin: Challanges Mount, But Sale Rumours Make For A Risky “Buy” Call Seeking Alpha
X1 month Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock Zacks
X1 month Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock Zacks
X2 months BioMarin (BMRN) Upgraded to Buy: Here’s Why Zacks
X2 months BMRN vs. INCY: Which Stock Is the Better Value Option? Zacks
X2 months Earnings call: BioMarin reports robust Q3 growth with VOXZOGO sales surge Investing.com
X2 months Royal Bank of Canada Reiterates “Sector Perform” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN) MarketBeat
X2 months BioMarin Q3 Earnings & Revenues Beat Estimates, ’24 Guidance Raised Zacks
X2 months BioMarin Pharmaceutical Inc. (BMRN) Q3 2024 Earnings Call Transcript Seeking Alpha
X2 months BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks
X2 months BioMarin Pharmaceutical (BMRN) to Release Quarterly Earnings on Tuesday MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.